Drug recall · December 11, 2024
Lisdexamfetamine Dimesylate Capsules recall
Why: Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37
- Lots / codes
Lot: 23274856A, Exp 04/30/2025
- Quantity
- 1608 bottles
- Company
- Lannett Company Inc., Seymour, IN
- Distribution
- Nationwide in the USA
- Initiated
- October 25, 2024 · Voluntary: Firm initiated
- Classified
- December 5, 2024
- Reported
- December 11, 2024
- Ended
- June 27, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lisdexamfetamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.